SCHEMBL2913180

SCHEMBL2913180

CC1(C(N)=O)CCCCC1(c1ccccc1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 1/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HDAC4 P56524 2/20 0.37
HSD11B1 P28845 2/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
MLYCD O95822 1/20 0.36
CCR2 P41597 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RORC P51449 2/20 0.35
NR1I2 O75469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472118 0.78 AKR1C1 (0.38) AKR1C1HDAC4SMN1; SMN2
SCHEMBL11307986 0.78 AKR1C1 (0.46) AKR1C1MEN1KMT2AHDAC4HSD11B1
SCHEMBL4991848 0.69 TRPA1 (0.36) AKR1C1
SCHEMBL3313096 0.69 ALDH1A1 (0.38) SMN1; SMN2RORCNR1I2
SCHEMBL28149790 0.68 AKR1C1 (0.46) AKR1C1MEN1KMT2AHDAC4
SCHEMBL28426673 0.68 AKR1C1 (0.53) AKR1C1MEN1KMT2AHDAC4HSD11B1
SCHEMBL42114 0.68 AKR1C1 (0.70) AKR1C1MEN1KMT2AHDAC4HSD11B1
SCHEMBL43810 0.66 AKR1C1 (0.68) AKR1C1MEN1KMT2AHDAC4HSD11B1
SCHEMBL3312805 0.66 BACE1 (0.35) MEN1KMT2ASMN1; SMN2RORCNR1I2
SCHEMBL518236 0.66 AKR1C1 (0.40) AKR1C1HDAC4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2214487-A1 NOVEL SEH INHIBITORS AND THEIR USE GlaxoSmithKline LLC (US) 2010-08-11 EP disclosed
WO-2009049157-A1 NOVEL SEH INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-04-16 WO disclosed